Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 2014

View Archived Issues

Janssen Therapeutics collaborates with USAID on multidrug-resistant TB initiative

Innate Immunotherapeutics expands compassionate use access to MS drug MIS-416

Pfizer initiates phase I trial of PF-06700841 in healthy adults and adults with plaque psoriasis

Inhibition of hydrogen sulfide gas production reduces chemotherapy-induced neuropathic pain

Arrest or reversion of liver disease by dual FXR/TGR5 agonist INT-767 in preclinical models

Alcon Research begins phase III trial of RTH-258

Novel anti-PD-L1/IL-15 fusion protein enhances immunological activity against tumor cells

OPKO Health and Pfizer enter into global agreement for hGH-CTP

Activity of fully human bispecific antibody against B-cell lymphoma described

FDA grants orphan drug status to ataluren for mucopolysaccharidosis type I

Galapagos regains rights to GLPG-1205

Allergan patent details novel EP2 receptor agonists for ocular diseases

Edison Pharmaceuticals develops compounds for oxidative stress disorders

Bristol-Myers Squibb researchers prepare MGAT2 inhibitors

XuanZhu Pharma patent divulges novel ALK inhibitors for cancer

Hinova Pharmaceuticals patents new AR antagonists

Cushing's syndrome treatment Ketoconazole HRA receives European marketing authorization

Ablynx initiates phase IIa trial of ALX-0171 in infants with RSV infection

FDA approves Ipsen's lanreotide depot for pancreatic and gastrointestinal neuroendocrine tumors

CSL Behring submits BLA to FDA for rIX-FP

Irisin identified as a biomarker for heart failure prognosis

Topline data from Auspex's First-HD study of SD-809

ADMA Biologics receives milestone payment for achievement of RI-002 clinical endpoints

Kymab to lead Wellcome Trust-funded Ebola virus consortium

FDA gives clearance to diaDexus Lp-PLA2 test for risk of coronary heart disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...